Biotech News Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (128)	7/5/2000 12:50:22 PM
From: Jim Oravetz	of 7143

FDA Finds Problems With Cancer Trials Using Interleukin Dow Jones Newswires WASHINGTON -- The Food and Drug Administration found problems with clinical trials using the drug interleukin to treat adult cancer patients, according to an FDA warning letter released Wednesday. The letter, as released to the public, doesn't reveal the sponsor of the drug trials or the drug's brand name, if any. The warning letter, dated June 20, was addressed to the Providence Cancer Center, which conducted the research. Interleukin is a type of biological modifier (polypeptide) that stimulates the growth of certain disease-fighting blood cells in the human system, and several companies are conducting clinical trials of gene therapies for the treatment of different diseases. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next